F.L. Putnam Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.6M Sell
28,724
-6,931
-19% -$2.81M 0.2% 100
2025
Q1
$17.7M Sell
35,655
-5,399
-13% -$2.69M 0.33% 64
2024
Q4
$21.4M Sell
41,054
-15,898
-28% -$8.27M 0.39% 55
2024
Q3
$27.7M Buy
56,952
+11,776
+26% +$5.73M 0.5% 44
2024
Q2
$25M Buy
45,176
+8,655
+24% +$4.79M 0.47% 43
2024
Q1
$21.2M Buy
36,521
+363
+1% +$211K 0.45% 51
2023
Q4
$19.2M Buy
36,158
+1,413
+4% +$750K 0.45% 52
2023
Q3
$17.6M Buy
34,745
+114
+0.3% +$57.7K 0.49% 47
2023
Q2
$18.1M Sell
34,631
-579
-2% -$302K 0.49% 45
2023
Q1
$20.3M Sell
35,210
-403
-1% -$232K 0.66% 38
2022
Q4
$19.6M Sell
35,613
-215
-0.6% -$118K 0.71% 37
2022
Q3
$18.2M Buy
35,828
+747
+2% +$379K 0.71% 37
2022
Q2
$19.1M Sell
35,081
-1,878
-5% -$1.02M 0.7% 38
2022
Q1
$21.8M Buy
36,959
+485
+1% +$286K 0.7% 37
2021
Q4
$24.3M Buy
36,474
+1,640
+5% +$1.09M 0.75% 37
2021
Q3
$19.9M Buy
34,834
+1,927
+6% +$1.1M 0.68% 43
2021
Q2
$16.6M Sell
32,907
-3,075
-9% -$1.55M 0.57% 48
2021
Q1
$16.4M Buy
35,982
+709
+2% +$324K 0.72% 40
2020
Q4
$16.4M Sell
35,273
-683
-2% -$318K 0.77% 36
2020
Q3
$15.9M Sell
35,956
-1,986
-5% -$877K 0.87% 35
2020
Q2
$13.7M Sell
37,942
-513
-1% -$186K 0.82% 38
2020
Q1
$10.9M Buy
38,455
+905
+2% +$257K 0.83% 38
2019
Q4
$12.2M Sell
37,550
-4,412
-11% -$1.43M 0.75% 42
2019
Q3
$12.2M Buy
41,962
+1,031
+3% +$300K 0.86% 34
2019
Q2
$12M Buy
40,931
+4,873
+14% +$1.43M 0.97% 31
2019
Q1
$9.87M Buy
36,058
+7,057
+24% +$1.93M 0.83% 38
2018
Q4
$6.49M Buy
29,001
+810
+3% +$181K 0.71% 50
2018
Q3
$6.88M Sell
28,191
-554
-2% -$135K 0.63% 56
2018
Q2
$5.95M Sell
28,745
-418
-1% -$86.6K 0.58% 58
2018
Q1
$6.02M Buy
29,163
+410
+1% +$84.6K 0.55% 62
2017
Q4
$5.46M Sell
28,753
-1,083
-4% -$206K 0.5% 65
2017
Q3
$5.65M Buy
+29,836
New +$5.65M 0.54% 63
2017
Q1
$2.85M Buy
18,558
+14,971
+417% +$2.3M 0.3% 84
2016
Q4
$506K Buy
+3,587
New +$506K 0.06% 149